Advances in the discovery & characterization of therapeutic antibodies

Monoclonal antibodies (mAbs) are one of the fastest-growing classes of biopharmaceuticals and represent highly successful treatment strategies for a broadening range of autoimmune, inflammatory, infectious, and immuno-oncology diseases. However, despite technological and methodological advancements, developing new mAbs can be time-consuming and cumbersome.

In this free eBook, you’ll discover how advances are being made in the discovery and characterization of therapeutic antibodies. This expert guide includes the latest antibody screening tools and how these can be leveraged to comprehensively assess novel mAbs, improve the identification and qualification of hits during screening, and accelerate and simplify drug discovery workflows.